Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA

Large Cap | Pharmaceuticals & Drugs

1847.30

12.90 (0.70%)

< Home < Back

Sun Pharmaceutical Industries informs about press release

Date: 10-02-2023

Sun Pharmaceutical Industries has informed that it enclosed Press Release relating to US FDA approval for generic Lenalidomide capsules.

The above information is a part of company’s filings submitted to BSE.